Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease | Zendy

Anand A. Dalal | Zendy; Douglas W. Mapel | Zendy; Melissa Roberts | Zendy; Hans Petersen | Zendy; Christopher Blanchette | Zendy

Open Access

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease

Author(s) -

Anand A. Dalal,

Douglas W. Mapel,

Melissa Roberts,

Hans Petersen,

Christopher Blanchette

Publication year - 2010

Publication title -

international journal of copd

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 67

eISSN - 1178-2005

pISSN - 1176-9106

DOI - 10.2147/copd.s15455

Subject(s) - medicine , salmeterol , fluticasone propionate , pulmonary disease , fluticasone , copd , anesthesia , corticosteroid , intensive care medicine

Relative costs and utilization-related outcomes of a fluticasone propionate 250 μg + salmeterol 50 μg combination (FSC), tiotropium bromide, and ipratropium as initial maintenance therapy in COPD have not been compared in a commercially-insured population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research